RBC Capital analyst Luca Issi raised the firm’s price target on Alnylam (ALNY) to $330 from $310 and keeps an Outperform rating on the shares.

RBC Capital analyst Douglas Miehm maintained a Buy rating on Knight Therapeutics (KHTRF – Research Report) yesterday and set a price target of ...

EXCLUSIVE: A top graphologist has revealed the reason behind Meghan Markle's decision to continue her use of the "crown" logo ...

Weleda refreshes its brand identity, reaffirming its Swiss roots to appeal to new audiences and strengthen its premium positioning.

Robert Warington, the founder of the Chemical Society, the predecessor of the Royal Society of Chemistry (RSC), has been ...

ConfirmTkt, India's leading online train-utility and ticketing platform, has renewed its association with Royal Challengers ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...

Innocan Pharma Ltd. Each Warrant is exercisable into one Common Share at a price of CAD$0.26 for a period of four (4) years from the date of issuance. Innocan intends to use the proceeds of the ...

A company named Aveo Pharmaceuticals, based in the outskirts of Mumbai, managed by Vinod Sharma is involved in the production, sale and exportation of a range of addiction pills containing a harmful m ...